Ibuprofen Tablet
Product Images NDC 72476-365

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Ibuprofen (NDC 72476-365). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Retail Business Services,llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

50 Count Caplet (300000520 R 00 Final)

50 Count Caplet (300000520 R 00 Final)
The given text contains information regarding a pain reliever and fever reducer medicine known as IBUPROFEN. It is available in the form of tablets and works as a Non-Steroidal Anti-Inflammatory Drug (NSAID). The text also mentions warnings related to its ingredients and suggests consulting a doctor before use. Apart from this, the text has various random words and numbers that are difficult to comprehend in the context, making the description less useful.*
FDA Label Image

100 Count Caplet (300000522 R 00 Final)

100 Count Caplet (300000522 R 00 Final)
FDA Label Image

24 Count Tablet (300000524 R 00 Final)

24 Count Tablet (300000524 R 00 Final)
FDA Label Image

50 Count Tablet (300000526 R 00 Final)

50 Count Tablet (300000526 R 00 Final)
FDA Label Image

100 Count Tablet (300000528 R 00 Final)

100 Count Tablet (300000528 R 00 Final)
FDA Label Image

200 Count Tablet (300000530 R 00 Final)

200 Count Tablet (300000530 R 00 Final)
This is a drug information leaflet for a pain reliever in tablet form. The drug contains ibuprofen and is used for relief from headaches, muscular aches, arthritis and menstrual cramps. The text contained dosage instructions, warnings, and precautions for use by pregnant or breastfeeding women, and people with certain health conditions such as high blood pressure, heart disease, liver cirrhosis, kidney disease, asthma, or those who have had a stroke. It also included information on possible side effects and interactions with other drugs such as aspirin. Instructions were also given on how to store the drug properly. The leaflet contained contact information for any questions or concerns about the product.*
FDA Label Image

500 Count Tablet (300000532 R 00 Final)

500 Count Tablet (300000532 R 00 Final)
FDA Label Image

1000 Count Tablet (300000533 R 00 Final)

1000 Count Tablet (300000533 R 00 Final)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.